Sound waves open brain barrier to attack deadly childhood tumor
NCT ID NCT05630209
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 24 times
Summary
This study tests whether using focused ultrasound to temporarily open the blood-brain barrier can safely deliver the chemotherapy drug doxorubicin to treat a rare and aggressive brain tumor called DIPG in children and young adults. Ten participants aged 5 to 21 will receive the treatment and be monitored for side effects and how well the drug reaches the tumor. The goal is to find a safer, more effective way to treat this difficult cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Cook Children's Health Care System
Fort Worth, Texas, 76104, United States
-
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
Conditions
Explore the condition pages connected to this study.